March 2020

Mar

Coronavirus Update from Biofortuna

In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure business continuity at Biofortuna.

Biofortuna

Biofortuna is a specialist contract development and manufacturing organisation providing Genomic services, custom development and manufacturing support.

Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 accreditation, ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.